These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
168 related items for PubMed ID: 17252538
1. Differential retention of alpha-vitamin E is correlated with its transporter gene expression and growth inhibition efficacy in prostate cancer cells. Ni J, Pang ST, Yeh S. Prostate; 2007 Apr 01; 67(5):463-71. PubMed ID: 17252538 [Abstract] [Full Text] [Related]
3. Tocopherol-associated protein suppresses prostate cancer cell growth by inhibition of the phosphoinositide 3-kinase pathway. Ni J, Wen X, Yao J, Chang HC, Yin Y, Zhang M, Xie S, Chen M, Simons B, Chang P, di Sant'Agnese A, Messing EM, Yeh S. Cancer Res; 2005 Nov 01; 65(21):9807-16. PubMed ID: 16267002 [Abstract] [Full Text] [Related]
5. RRR-alpha-tocopheryl succinate inhibits human prostate cancer cell invasiveness. Zhang M, Altuwaijri S, Yeh S. Oncogene; 2004 Apr 15; 23(17):3080-8. PubMed ID: 15048090 [Abstract] [Full Text] [Related]
6. Alpha-vitamin E derivative, RRR-alpha-tocopheryloxybutyric acid inhibits the proliferation of prostate cancer cells. Chang E, Ni J, Yin Y, Lin CC, Chang P, James NS, Chemler SR, Yeh S. Asian J Androl; 2007 Jan 15; 9(1):31-9. PubMed ID: 17187157 [Abstract] [Full Text] [Related]
9. RRR-alpha-vitamin E succinate potentiates the antitumor effect of calcitriol in prostate cancer without overt side effects. Yin Y, Ni J, Chen M, Guo Y, Yeh S. Clin Cancer Res; 2009 Jan 01; 15(1):190-200. PubMed ID: 19118046 [Abstract] [Full Text] [Related]
10. Vitamin E succinate inhibits NF-kappaB and prevents the development of a metastatic phenotype in prostate cancer cells: implications for chemoprevention. Crispen PL, Uzzo RG, Golovine K, Makhov P, Pollack A, Horwitz EM, Greenberg RE, Kolenko VM. Prostate; 2007 May 01; 67(6):582-90. PubMed ID: 17262802 [Abstract] [Full Text] [Related]
12. Gene expression of survivin and its spliced isoforms associated with proliferation and aggressive phenotypes of prostate cancer. Koike H, Sekine Y, Kamiya M, Nakazato H, Suzuki K. Urology; 2008 Dec 01; 72(6):1229-33. PubMed ID: 18336887 [Abstract] [Full Text] [Related]
14. Overexpression of 5 alpha-reductase type 1 increases sensitivity of prostate cancer cells to low concentrations of testosterone. Thomas LN, Douglas RC, Rittmaster RS, Too CK. Prostate; 2009 May 01; 69(6):595-602. PubMed ID: 19125422 [Abstract] [Full Text] [Related]